CIK 0001699031
- Non-accelerated filer
- Emerging growth company
GRAIL, Inc.
Sign in to watch- Ticker
- GRAL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 863673636
- Phone
- +1 833-694-2553
- Business address
- 250 S. MATHILDA AVENUE, SUITE 100, SUNNYVALE, CA, 94086
- Former names
- GRAIL, LLC
- 4 Grant or award Director acquired 1,828 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 30,452 shares at $14.02 ($426,937)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 31,055 shares (grant or award)
- 4 Grant or award Director acquired 210 shares (grant or award)
- 4 Grant or award Director acquired 248 shares (grant or award)
- 4 Grant or award Director acquired 296 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 978 shares (grant or award)
- 4 Grant or award Director acquired 1,656 shares (grant or award)
- 4 Grant or award Director acquired 1,054 shares (grant or award)
- 4 Open-market sale Chief Executive Officer sold 123,454 shares at $14.02 ($1,730,825)
- 4 Open-market buy 10% owner bought 78,829 shares at an average $13.00 ($1,024,698)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Executive Officer acquired 260,080 shares (grant or award)
- 4 Grant or award President acquired 259,780 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 125,300 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 15,641 shares at $16.25 ($254,121)
- 4 Open-market sale President sold 74,084 shares at $16.25 ($1,203,650)
- 4 Grant or award Chief Executive Officer acquired 475,178 shares (grant or award)
Page 5 of 6 · 115 filings